
Sign up to save your podcasts
Or


Did you know that almost 90% of all product ideas fail in clinical trials?
Surprising to me was that lack of efficacy doesn't seem to be the main reason why clinical trials fail in the first place. Other factors are at play, and most of them are manageable risks when the right team is at work.
In this episode:
Who is the expert in the show?
Heike Schön, Lumis International GmbH with more than 25 years of experience in international clinical research and drug development.
📞 Book a meeting here: Link
📰 Article: Medium
Youtube: https://youtu.be/r0qphO8Qs3o
Podcast notes: Link
Timestamps:
(00:00) Intro
(02:25) Who Is Heike Schön, Lumis International and Lumis Consulting?
(04:20) Topics in the Episode
(04:30) Kick-Off
(05:00) Background to Lumis International and Heike Schön
(10:20) When is the Right Time to Start with the Planning of a Clinical Trial?
(12:10) The Role of a Sponsor of a Clinical Trial
(14:30) Who is Responsible for the Clinical Trial as a Sponsor?
(16:55) When Should a Company Start to Implement Clinical Trial Management in the Organisation?
(18:30) Funding Requirements for Clinical Trials
(20:00) The Reality of Inhouse and Outhouse Clinical Trial Management
(22:15) What to Think About When Planning Oversight Management
(25:00) Relationship and Culture Management in Clinical Trials
(27:25) Budget and Ressource Requirement for Clinical Trials
(28: 45) 3 Steps to a Successful Clinical Trial
(30:40) The 3 Main Reasons Why Clinical Trials Fail
(33:30) Considerations for Patient Enrollment as a Key Success Factor for Clinical Trials
(37:30) … and when enrolment fails, what are the steps to rescue the trial?
(42:45) Do Inhouse Studies Require Rescue?
(44:30) How to Rescue a Clinical Trial
(48:30) Root Cause Analysis as a Starting Point to Rescue a Trial
(52:25) Preventive Measures to Avoid Failure Early on
(53:30) How Important is Leadership in a Clinical Trial?
(56:30) The 3 Main Reasons to Stop a Clinical Trial – The Point of no Return
(59:00) How are the Cost Calculated for Rescue Study Management?
(01:00:15) Planning of a Clinical Trial – A Key Aspect of a Successful Trial
(01:02:15) How to Plan Realistic Timelines and Numbers
(01:07:15) The Role of Feasibility Studies in Clinical Trials
(01:09:30) How Clinical Trial Management Evolved in the last 30 years
(01:11:15) Upcoming Trends in Clinical Trial Management
(01:13:15) Decentralized Clinical Trials
(01:15:00) Artificial Intelligence And Big Data in Clinical Trial Management
(01:17:55) The Digital Twin
(01:19:15) The Human Factor and Leadership in Clinical Trial Management
(01:21:10) The Patient in Clinical Trials
(01:22:55) Planning and its contribution to clinical trial success
(01:26:55) Summary of What to Do When Clinical Trials Fail
(01:28:35) When is the Right Time to Add a Rescue Team to the Clinical Trial?
(01:31:00) A Risk Management Plan for Clinical Trials
(01:32:00) Contact
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Big corporations strive to bring new solutions to their customers to help them solve their most pressing problems.
To do so the corporation needs to be innovative. That's why companies like Apple, Google, Pfizer, and similar players want to cooperate with start-ups and scale-ups globally.
Such cooperations strive to collaborate with top startups, invest in them, and sometimes acquire them to have access to novel ideas. By innovating the big players stay competitive, secure growth, and also help keep their employees motivated and curious.
One of the best ways to foster innovation is creating Venture Capital funds. Venture funds collect capital to invest in high-risk early-stage innovative startups to help them grow.
In this episode, we talk about:
Who is the expert in the show?
Bruno Montanari is a Partner at Seroba. He has a background in venture capital and in investment banking, with a focus on the pharmaceutical, biotechnology, and medical device industries.
Bruno sits on the boards of STORM Therapeutics and Coave Therapeutics.
Youtube: https://youtu.be/nG8DspNug-4
Timestamps:
(00:00) Introduction
(03:30) Start of the Conversation “How Venture Capital Supports Science & Innovation”
(03:45) What is Venture Capital?
(07:30) Why is Venture Capital Necessary?
(08:35) How Capital Intensive is Drug Development in Life Science?
(11:55) Why Do Research Organisation and Big Pharma Need Companies in Between the Value Chain?
(17:15) How Much Capital is Needed to Bring a New Therapy to the Market?
(19:10) Why do some Life Science Start-Ups Fail?
(24:30) How Can Venture Capital Help to Build Europe Into a Startup Continent?
(31:53) How Innovation Changes the World
(32:40) The Entrepreneurship Mindset between Academia and Industry
(36:45) The State of Venture Capital in Europe
(39:00) Elements Needed to Develop the Life Science Industry in Europe
(42:35) Why Do Life Science Companies in Europe get Listed on the NASDAQ?
(49:00) The Advantages of Specialized Investors
(50:50) Benefits for Family Offices and High Networth Individuals to Invest in a Venture Fund Rather than directly into early-stage startup companies
(59:00) Seroba Life Sciences
(01:00:40) Success Stories from the Venture Capital Life
(01:06:15) What kind of Deals are VCs looking for?
(01:09:15) The Importance of Gathering Information before Closing a Deal – on both sides of the negotiation table
(01:14:10) How to Balance Pitching and Relationship Building
(01:19:30) 2x/10x/100X – Why are these metrics important to VCs
(01:23:30) Deal Closed and they lived happily ever after – How does life look like post-investment?
(01:27:00) How VCs Support Their Portfolio Companies
(01:31:35) Warren Buffett vs. Venture Capital – Why is an Exit Important to VCs?
(01:39:00) How to Reach Out to Bruno Montanari and Seroba Life Science
Podcast Links:
Podcast Community: https://lsg2g.substack.com/
Community Partner: https://linktr.ee/lsg2g
Christian Soschner: https://linktr.ee/soschner
Podcast Episodes: https://pod.link/1493847125
Send us Fan Mail
The LSG2G PartnersSupport the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Lately, investors and researchers have published more and more information on longevity research and development.
Investors like Sergey Young or Christian Angermayer started to bet significant capital on this topic.
What is going on in this field on the research side? What are potential applications to increase the Lifespan? And when will those innovations hit the market?
In this episode, I had a conversation in December 2021 with Prof. Collin Ewald, ETH Zürich, about his longevity research and the future impact on the pharma industry.
In this episode, we talk about:
Who is the expert in the show?
Prof. Ewald is Head of the Extracellular Matrix Regeneration Laboratory, Department of Health Sciences and Technology.
Collin has a longstanding interest in the molecular biology of healthy aging and age-related pathologies.
He is the founder and currently the president of the Swiss Society for Aging Research (www.ssfar.ch). He is named under the top 1000 Longevity Leaders worldwide and the top 15 Longevity Influencers in Switzerland. He has received multiple awards, including NYAS Future Entrepreneur, recognized by the New York Academy of Sciences.
Youtube: https://youtu.be/7uH3m6spb_g
Timestamps:
(00:00) Opening about the situation in Switzerland and Austria in December 2021
(05:40) Longevity, Ageing, and the Health Span
(07:05) Collin Ewald – Development of Ageing Research since the 90s
(10:45) What is Ageing?
(16:45) What is the Possible Lifespan of Human Beings? From Stone Age to the Future
(20:10) What Factors Changed in Society that helped increase the average Lifespan?
(22:45) The Importance of Education on Healthy Aging
(26:15) How Education and Research Evolved with the Internet
(27:00) Research Focus of the Collin Ewald Lab
(33:30) Doubling the Lifespan in lab trials – is it possible to translate the research into human applications?
(35:40) How to Translate Research into Products with Spin Outs.
(38:00) Spin Outs from the Collin Ewald Lab
(47:24) The Role of Extracellular Matrix in Ageing
(54:40) The Potential for Applications for Cancer Diagnostic rooted in the research of the Collin Ewald Lab
(56:15) How Artificial Intelligence Helps in Research
(59:45) The Challenges Longevity Drug Development Faces at the Clinical Stage
(01:03:45) The Role of Food & Science in Longevity Research
(01:07:45) The Swiss Society of Ageing Research & Health Policies
(01:13:00) Development of Life Expectancy
(01:17:20) Healthy Ageing and Social Security
(01:20:25) Advice to Young People Who Want to Create Lasting Change
(01:25:35) The Killer Experiment - How Failure Creates Success
Podcast Links:
Podcast Community: https://lsg2g.substack.com/
Community Partner: https://linktr.ee/lsg2g
Christian Soschner: https://linktr.ee/soschner
LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
What significant problems does the food industry face today? Which solutions are already in development?
In this episode, I am talking with Mauricio Agudelo and Lina María Toro about Sustainable Food Innovation in South America.
BIALTEC assists animal protein producers to improve productivity and profitability through precision nutrition, understanding their particular dietary needs, analyzing them through a bioinformatics platform that uses artificial intelligence, and supplying the next generation antibiotic-free additives that will facilitate performance to obtain the desired results.
In this episode, we talk about:
I hope you enjoy the conversation the same way I did.
Who are the experts in the show?
Shownotes: tbd
Youtube: https://youtu.be/8S--mLaRJ4w
Timestamps:
(00:00) Intro
(02:30) Opening
(05:45) Recap of EFIB October 2021
(09:15) The Major Problems in the Food Industry in South America, North America, and Europe
(11:40) Use of Antibiotics in Agriculture
(12:45) The Two Big Problems in Agriculture
(13:45) Precision Farming and Precision Agriculture: Using AI, Big Data and Gene Editing
(16:20) Bialtec’s Mission
(19:50) Solution of Bialtec for Precision Farming
(24:15) The Importance of the Microbiome
(30:20) Big Data, Health, and Nutrition
(31:50) Let Food be thy medicine and medicine be thy Food.
(33:30) The global increase in meat consumption
(36:15) Sustainability
(38:30) Motivation to create a StartUp
(46:45) The Start-Up Eco-System in Colombia
(50:45) Live Your Dreams
(54:00) Opportunity for US and EU Bases Investors in Latin America
(58:45) Bialtec’s Plans for European Expansion
(01:01:45) What is Bialtec Looking for?
Podcast Links:
Podcast Website: https://www.lifescienceget2gether.com/
Podcast Community: https://lsg2g.substack.com/
Community Partner: https://linktr.ee/lsg2g
Christian Soschner: https://linktr.ee/soschner
LSG2G Twitter: https://twitter.com/LGet2gether
LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
Podcast Episodes: https://pod.link/1493847125
Episodes on YouTube: https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Innovation needs collaboration on a global scale. Making things happen requires entrepreneurs who love science and work day and night to connect the best minds globally and support them to translate their science into products and businesses.
In this episode, I have a conversation with Kai Lamottke, CEO and Co-Founder of Bicoll.
Dr. Kai Lamottke is co-founder & CEO of Bicoll GmbH and Bicoll Biotechnology (Shanghai) Co. Ltd., the first German-Chinese biotechnology company. His expertise and knowledge in life science and innovation sectors in China and Europe are requested by corporates, SMEs, and organizations, like European Commission. The excessive network of business, academic and political contacts allowed him to achieve business governmental grants with a value of over 23 Mio. € up to now
The Bicoll Group is a privately-owned biopharmaceutical company which includes Bicoll GmbH headquartered near Munich in Planegg / Martinsried, Germany, and its wholly-owned subsidiary Bicoll Biotechnology (Shanghai) Co. Ltd.
In this episode, we talk about
I hope you enjoy the conversation the same way I did.
Who is the Expert in the show?
Shownotes: https://lsg2g.substack.com/p/67-kai-lamottke-bringing-innovation
Video to the Episode: https://youtu.be/K5_7nKZ6KCI
Timestamps:
(00:00) Start
(02:30) Science During the Pandemic
(07:05) Introduction Kai Lamottke and Bicoll
(13:00) Entrepreneurship
(17:30) Bicoll’s Mission
(19:50) The Process of Finding a Business Model – Example Bicoll
(25:00) World of Entrepreneurship
(29:15) The Magic of Drug Discovery
(35:00) How to Deal with Failure
(41:00) How to Start a Company in China
(47:45) Founding Companies in Asia at the beginning of the Millenium
(51:45) How to Communicate Across Continents Without Social Media, Smartphone and Highspeed Data Highways?
(57:45) Managing International Business in a Pandemic World
(01:01:30) Similarities and Differences Between Asian and European Work Ethics
(01:09:05) The Benefits of the Chinese Education System
(01:16:10) What is the Best First Step Into the Chinese Market?
Podcast Links:
Podcast Website: https://www.lifescienceget2gether.com/
Podcast Community: https://lsg2g.substack.com/
Community Partner: https://linktr.ee/lsg2g
Christian Soschner: https://linktr.ee/soschner
LSG2G Twitter: https://twitter.com/LGet2gether
LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
Podcast Episodes: https://pod.link/1493847125
Episodes on YouTube: https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Part 7 of the Year in Review Recording.
1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts.
What was hot in 2021, and what do our speakers expect for 2022?
In this episode, we talk about
I hope you enjoy the conversation the same way I did.
Who are the Experts in this episode:
Video to the Episode: https://youtu.be/d4_aQMOabb8
Timestamps:
(01:00) Martin Popilka – Pivoting from Formula 1 Race Fuels to Hand sanitizer During the Pandemic
(05:30) Hand Sanitizer as a Service for Companies
(08:00) Data Collection and GDPR Compliance
(11:15) Plans for 2022
(12:00) Challenges of Running 3 Companies at the same time
(15:15) P1 Fuels
(21:30) Hand sanitizing to Stay Healthy – Will it Stay After the Pandemic?
(25:15) How Was the Experience of Recording 7:30 Hours Straight?
(33:12) Denis Roio – Open Source
(46:00) Dyne.org
(52:00) Techies against Technocracy
Podcast Links:
Community Partner: https://linktr.ee/lsg2g
Christian Soschner: https://linktr.ee/soschner
Podcast Community: https://lsg2g.substack.com/
LSG2G Twitter: https://twitter.com/LGet2gether
LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
Podcast Episodes: https://pod.link/1493847125
Episodes on YouTube: https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV
Podcast Website: https://www.lifescienceget2gether.com/
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Part 6 of the Year in Review Recording.
1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts.
What was hot in 2021, and what do our speakers expect for 2022?
In this episode, we talk about
I hope you enjoy the conversation the same way I did.
Who are the Experts in this episode:
Video to the Episode: https://youtu.be/RpPpO5hDlBI
Timestamps:
(02:00) What are NFTs?
(03:42) The Metaverse
(04:08) More about NFTs
(07:20) NanoMetaGames
(17:00) NFTs in Games
(19:13) NFT and digital collectibles from games
(22:57) Usecases for NFT
(23:53) When You Have Just 1 Wine and 1 NFT…
(25:09) What Do a Shirt and an NFT Have in Common?
(27:45) What Legal Challenges do NFTs Face Today?
(34:21) NanoMetaGames – Outlook for 2022
(36:00) Markus Raunig – Austrian Startups – How was 2021?
(37:00) The Austrian Entrepreneurship Week
(39:37) From Morning Moonshots to Future Weekly
(41:00) The backstory to Future Weekly – How did it all start?
(43:45) The Three Biggest Success @ Future Weekly
(45:39) The Apple & Spotify Charts Algorithm
(48:26) Outlook for 2022
Podcast Links:
Community Partner: https://linktr.ee/lsg2g
Christian Soschner: https://linktr.ee/soschner
Podcast Community: https://lsg2g.substack.com/
LSG2G Twitter: https://twitter.com/LGet2gether
LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
Podcast Episodes: https://pod.link/1493847125
Episodes on YouTube: https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV
Podcast Website: https://www.lifescienceget2gether.com/
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Part 5 of the Year in Review Recording.
1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts.
What was hot in 2021, and what do our speakers expect for 2022?
In this episode, we talk about
I hope you enjoy the conversation the same way I did.
Who are the Experts in this episode:
Video to the Episode: https://youtu.be/O8hsqfEVgmI
Timestamps:
(00:00) – Walter Stockinger - Introduction Hadean Ventures
(01:00) – Success 2022 – Hadean Ventures
(03:00) – Personal Interactions Matter
(03:36) – Work-Life at Hadean Ventures During the Pandemic
(05:18) – The Effects of the Pandemic on Travelling and the Learnings that Came with it
(07:18) – Portfolio Success in 2021
(11:52) – Difference of Ticket and Round Sizes in Europe and the US
(14:00) – Availability of Capital on the Market for Life Science Projects
(17:11) – Future Potential of ADCs in Oncology
(23:51) – The Future of mRNA Vaccines
(28:47) – Outlook for 2022
(30:00) – Yoni Falkson – Introduction
(31:05) – Gilgamesh Pharmaceutical and Podcast notes
(33:38) – Psychedelic Drug Development – Players on the field
(35:52) – Fundraising in the United States during the Pandemic
(38:04) – The Psychedelic Drug Development Area
(40:50) – Development of Mental Health in the US
(44:10) – Microbiome, Mental Health, and Diagnostics
(47:44) – Mission of Podcast Notes
(51:35) – Podcast notes, Beginner’s Mind, and the Antibacterial Space
(54:23) - The Podcast Notes Community
(55:37) The USP of Podcast Notes
(56:21) Outlook for 2022 – Yoni Falkson
Podcast Links:
Community Partner: https://linktr.ee/lsg2g
Christian Soschner: https://linktr.ee/soschner
Podcast Community: https://lsg2g.substack.com/
LSG2G Twitter: https://twitter.com/LGet2gether
LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
Podcast Episodes: https://pod.link/1493847125
Episodes on YouTube: https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV
Podcast Website: https://www.lifescienceget2gether.com/
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Part 4 of the Year in Review Recording.
1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts.
What was hot in 2021, and what do our speakers expect for 2022?
In this episode, we talk about
I hope you enjoy the conversation the same way I did.
Who are the Experts in this episode:
Video to the Episode: https://youtu.be/IGybV1SsTko
Timestamps:
(00:00) Opening Christian Soschner / Albert Missbichler
(02:00) Peter Llewellyn-Davies Biotech in Austria
(03:22) How was 2021 for Life Science Entrepreneurs?
(05:12) How was 2021 for Biotech Austria?
(06:45) The situation of Life Science Infrastructure in Austria
(08:00) Lab Space in Austria
(09:30) Europe Needs a Culture of Success
(12:25) English Proficiency in Austria
(14:08) Agenda 2022 – Biotech Austria – 3 Main Goals
(16:30) Goal #4: Availability of Capital for Life Science Investments
(18:10) Goal #5: Availability of Funding for Clinical Trials
(19:30) Goal #6: Have Fun
(20:15) Astrid Wollard / Christian Soschner / Matthias Tarasiewicz– Education – Health and Financial Literacy – Beginner’s Mindset
(25:30) Why Beginner’s Mind Matters More Than Ever
(28:18) The Entrepreneurial Spirit in Oxford
(30:05) How Did the Start-Up Scene in Europe Evolve since the 90s?
(32:25) Albert Missbichler – Entrepreneurship & Business Angel in Life Science
(35:00) Fianostics – Diagnostics during Covid
(37:25) From Prototype Stage to Market Entry
(38:35) How Important Is Market and Financing Expertise in the Early Stages of a Company?
(43:04) Entrepreneurship Mindset and Customer Needs
(47:00) Outlook to 2022 – Importance of Meeting in Real Life
(49:20) Direct Contact to Customers in the Digital World
(52:00) Content Marketing Helps to Build Trust Online
(56:30) How Building Business Relationships Changed During the Pandemic
Podcast Links:
Community Partner: https://linktr.ee/lsg2g
Christian Soschner: https://linktr.ee/soschner
Podcast Community: https://lsg2g.substack.com/
LSG2G Twitter: https://twitter.com/LGet2gether
LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
Podcast Episodes: https://pod.link/1493847125
Episodes on YouTube: https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV
Podcast Website: https://www.lifescienceget2gether.com/
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Part 3 of the Year in Review Recording.
1 hour 15 minutes of exciting conversations with speakers from previous podcast episodes and business partners of the hosts.
What was hot in 2021, and what do our speakers expect for 2022?
In this episode, we talk about
I hope you enjoy the conversation the same way I did.
Who are the Experts in this episode:
Video to the Episode: https://youtu.be/CkYOd0q9B-A
Timestamps:
(00:00) Christian Soschner & Stefanie Rösel – Podcast & Content Marketing
(03:45) The Gary V. Content Strategy Applied at the Podcast
(05:30) What Kind of Companies Can Use A Podcast for Their Marketing Purposes?
(07:15) Valuations – Quo Vadis?
(11:35) Macro Trends & Market Crashes
(17:15) Johannes Sarx and Philipp Hainzl – How Did Life Science Evolve in the Last 10 Years in Austria – Audio Only
(18:00) More than 1,000 Life Science Companies in Austria
(22:35) Marinomed, Tamirna, or Valneva – Companies that started before 2008 in Austria
(25:35) Expectations for 2022 – Will the Industry Move Forward at the Same Speed Like in 2020-21?
(28:45) EIT Health – Co-Location Center in Vienna
(30:10) In-Person Events in Austria in 2022
(33:00) Stefanie Rösel – Life Science Content Marketing & Social Media
(35:35) How The Pandemic Changed The Behaviour in Business on Social Media
(37:16) The Digital Presence of People and Companies Matters More Than Ever
(39:45) Why Online Content Marketing Matters for B2B Companies
(42:41) The Most Important Platforms for B2B Companies in 2022
(44:00) Biggest Lesson From 2021
(45:50) Outlook for 2022 – Content marketing
(46:35) How Will the Transition von Web 2.0 to Web 3.0 affect Content Marketing
(51:45) Julia Resch – Vienna Stoch Exchange – 250 Years
(52:35) The Austrian Stock Market in 2021 – 40% Performance
(53:45) The European IPO Market
(54:15) Life Science and the European Stock Market
(55:40) Industries on the Austrian Stock Exchange
(56:35) Investment Trends from the Austrian Stock Market Perspective
(57:50) Digital Assets on the Stock Markets
(01:01:35) Outlook 2022 on the Stock Market
(01:03:45) Matthias & Astrid - Overview over Topics from Year in Review
(01:07:35) What was going on in Tech in 2021
(01:12:35) Content Marketing for Profiling
Podcast Links:
Community Partner: https://linktr.ee/lsg2g
Christian Soschner: https://linktr.ee/soschner
Podcast Community: https://lsg2g.substack.com/
LSG2G Twitter: https://twitter.com/LGet2gether
LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
Podcast Episodes: https://pod.link/1493847125
Podcast Website: https://www.lifescienceget2gether.com/
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link